tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ABBV Stock Latest News

Fake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
Market NewsFake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
2d ago
ABBV
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
PremiumMarket News
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
4d ago
CVS
SPX
AbbVie presents results from ongoing Phase 3 study of oral atogepant
PremiumThe Fly
AbbVie presents results from ongoing Phase 3 study of oral atogepant
7d ago
ABBV
AbbVie pullback brings attractive entry point, says JPMorgan
PremiumThe Fly
AbbVie pullback brings attractive entry point, says JPMorgan
9d ago
ABBV
AbbVie (NYSE:ABBV) Trims EPS Outlook, Stock Drops
PremiumMarket News
AbbVie (NYSE:ABBV) Trims EPS Outlook, Stock Drops
14d ago
ABBV
Oppenheimer more bullish on Aldeyra, upgrades to Outperform
PremiumThe FlyOppenheimer more bullish on Aldeyra, upgrades to Outperform
16d ago
ABBV
ALDX
AbbVie put volume heavy and directionally bearish
PremiumThe Fly
AbbVie put volume heavy and directionally bearish
16d ago
ABBV
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
PremiumMarket News
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
18d ago
ABBV
LABP
AbbVie price target raised to $195 from $185 at Barclays
PremiumThe Fly
AbbVie price target raised to $195 from $185 at Barclays
23d ago
ABBV
Fly Insider: NextNav, Akamai among week’s notable insider trades
PremiumThe Fly
Fly Insider: NextNav, Akamai among week’s notable insider trades
24d ago
NN
ABBV
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
25d ago
ABBV
LABP
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PremiumPress Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
25d ago
ABBV
LABP
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
PremiumThe FlyAbbVie to acquire Landos Biopharma got $20.42 per share in cash
25d ago
ABBV
LABP
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
25d ago
ABBV
LABP
AbbVie confirms FDA grants full approval for Elahere for certain ovarian cancers
PremiumThe Fly
AbbVie confirms FDA grants full approval for Elahere for certain ovarian cancers
27d ago
ABBV
FDA approves mirvetuximab soravtansine-gynx for certain cancers
PremiumThe Fly
FDA approves mirvetuximab soravtansine-gynx for certain cancers
27d ago
ABBV
AbbVie price target raised to $190 from $188 at Guggenheim
PremiumThe Fly
AbbVie price target raised to $190 from $188 at Guggenheim
28d ago
ABBV
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
1M ago
AZN
BMY
Allergan Aesthetics announces FDA approval of JUVEDERM VOLUMA XC
PremiumThe Fly
Allergan Aesthetics announces FDA approval of JUVEDERM VOLUMA XC
1M ago
ABBV
AbbVie makes milestone payment to Dragonfly after dosing in solid tumor trial
PremiumThe FlyAbbVie makes milestone payment to Dragonfly after dosing in solid tumor trial
1M ago
ABBV
AbbVie, OSE Immunotherapeutics enter pact to develop OSE-230
PremiumThe Fly
AbbVie, OSE Immunotherapeutics enter pact to develop OSE-230
2M ago
ABBV
Regenxbio expects cash to fund operations into 2H25
PremiumThe Fly
Regenxbio expects cash to fund operations into 2H25
2M ago
ABBV
RGNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >